These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8732663)

  • 21. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring and reporting errors in surgical pathology. Lessons from gynecologic cytology.
    Renshaw AA
    Am J Clin Pathol; 2001 Mar; 115(3):338-41. PubMed ID: 11242788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putting the Papanicolaou smear in perspective.
    Zastrow RC
    Arch Pathol Lab Med; 1997 Mar; 121(3):225-6. PubMed ID: 9111104
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic error using ultrasound. Potential risks caused by deficient quality assurance by the manufacturer].
    Schwing C
    Fortschr Med; 1985 Apr; 103(14):82-3. PubMed ID: 3888802
    [No Abstract]   [Full Text] [Related]  

  • 29. [Berit is cytology assistant--I want to have more time at the microscope. Interview by Jan Bärtås].
    Persson B
    Vardfacket; 1991 Mar; 15(6):4-5. PubMed ID: 1669729
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic vigilance.
    Fowkes FG
    Lancet; 1986 Mar; 1(8479):493-4. PubMed ID: 2869221
    [No Abstract]   [Full Text] [Related]  

  • 31. The uses of error: quality control.
    Baum M
    Lancet; 2001 Mar; 357(9261):1007. PubMed ID: 11293593
    [No Abstract]   [Full Text] [Related]  

  • 32. Error in medicine.
    Orkin FK
    JAMA; 1995 Aug; 274(6):459-60; author reply 460-1. PubMed ID: 7629951
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic variability versus diagnostic errors in cytology].
    Dalla Palma P
    Pathologica; 2001 Oct; 93(5):593-5. PubMed ID: 11725366
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing the error rate in Papanicolaou smears. One laboratory's experience with the PAPNET system.
    Koss LG
    Physician Assist; 1994 Dec; 18(12):48-52. PubMed ID: 10139375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Errors in cervical smears: minimizing the risk of medicolegal consequences.
    Greening SE
    Monogr Pathol; 1997; (39):16-39. PubMed ID: 9249818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance cytology error tracking system for negative GYN case rescreen.
    Maloney JA
    Diagn Cytopathol; 1996 May; 14(3):282-3. PubMed ID: 8732663
    [No Abstract]   [Full Text] [Related]  

  • 38. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.